Although it is well known that the hippocampal CA1 sub®eld is highly vulnerable to ischemic injury, cellular mechanisms leading to this neuronal degeneration are not fully understood. Using organotypic cultures of rat hippocampal slices, we determined whether phospholipase A 2 (PLA 2 ) is activated in response to ischemic conditions (OGD; oxygen and glucose deprivation). The PLA 2 activity in the pyramidal cell layer increased immediately following a 35-min exposure to OGD, which was likely to be mediated by selective activation of cytosolic Ca 2+ -dependent PLA 2 subtype (cPLA 2 ). This enhancement lasted for at least 24 h. Interestingly, no apparent increase was detected in the dentate gyrus. Twenty-four hours after the OGD exposure, neuronal death was detected mainly in the CA1 region of hippocampal slices. To examine whether the PLA 2 activation is causally or protectively involved in the ischemic injury, we investigated the effect of pharmacological blockade of PLA 2 on the OGD-induced neuronal death. The PLA 2 inhibitor bromophenacyl bromide ef®ciently prevented the cell death in a concentration-dependent manner. Similar results were obtained for the selective cPLA 2 inhibitor AACOCF 3 . However, the Ca 2+ -independent PLA 2 inhibitor bromoenol lactone and the secretory PLA 2 inhibitor LY311727 were virtually ineffective. These results suggest that cPLA 2 plays a causative role in the neuronal death following OGD exposure. Thus, the present study may provide novel therapeutic targets for the development of neuroprotective agents.
Introduction
In cerebral ischemia, a reduction in the supply of glucose and oxygen leads to a complex cascade of cellular events, eventually resulting in neuronal death (Siesjo, 1992a (Siesjo, , 1992b . Both clinical and experimental studies on transient forebrain ischemia revealed that the hippocampus, particularly the CA1 sub®eld, is highly vulnerable to ischemic injury (Schmidt-Kastner & Freund, 1991; Diemer et al., 1993) . However, mechanisms underlying this regional speci®city in vulnerability remain to be determined.
Arachidonic acid and its metabolites, e.g. prostaglandins, leukotrienes and other eicosanoids, exert a variety of neuromodulatory actions in the central nervous system such as fever generation, sleep± wakefulness regulation, pain and olfactory sensation and neuroendocrine regulation (Shimizu & Wolfe, 1990; Matsumura et al., 1998) . The initial step of the arachidonate cascade is mediated by phospholipase A 2 (PLA 2 ) that hydrolyses the sn-2 fatty acyl ester bond of glycerophospholipids to release free arachidonic acid and lysophospholipids. At present, mainly three types of PLA 2 s are identi®ed, i.e. cytosolic Ca 2+ -dependent PLA 2 (cPLA 2 ), cytosolic Ca 2+ -independent PLA 2 (iPLA 2 ), and the secretory form of PLA 2 (sPLA 2 ) (Dennis, 1997) .
The hippocampus is a prominent site of expression of PLA 2 (Molloy et al., 1998; Kishimoto et al., 1999) , and the release of arachidonic acid from membrane phospholipids and subsequent initiation of the arachidonic acid cascade are a well-documented observation following transient global ischemia (Rehncrona et al., 1982; Abe et al., 1987; Hsu et al., 1989) . However, it remains unclear how these PLA 2 metabolites contributes to ischemic injury. We have focused the present study on the role of PLA 2 in ischemia-induced neuronal death. Using organotypic cultures of hippocampal slices, this work shows for the ®rst time that ischemic conditions cause an increase in hippocampal PLA 2 activity, and also that PLA 2 inhibitors attenuated the ischemic injury in the hippocampus. essential medium (Life Technologies, Grand Island, NY, USA), 25% horse serum (Cell Culture Laboratory, Cleveland, OH, USA), and 25% Hanks' balanced salt solution (HBSS), and were maintained in a humidi®ed incubator at 37°C in 5% CO 2 , and the medium was changed every 3 days. The cultures were used at 12±13 days in vitro.
Combined oxygen-glucose deprivation (OGD/ischemia) experiments were performed in a chamber containing an anaerobic gas mixture (95% N 2 and 5% CO 2 ). The culture medium was replaced with deoxygenated glucose-free HBSS. During the deprivation procedure, cells were placed in a humidi®ed 37°C incubator for 35 min. Deprivation was terminated by replacing the exposure medium with normal medium containing 0.5 mg/mL propidium iodide (PI) (Molecular Probes, Eugene, OR, USA). The cultures were then incubated in a CO 2 incubator at 37°C for 24 h. Fluorescence images of PI were obtained with the Bio-Rad MRC-600 confocal imaging system (Bio-Rad Microscience Division, Cambridge, MA, USA). Pixel¯uorescence intensity of 8-bit resolution was measured at three different areas of the slice, i.e. the CA1 and CA3 stratum pyramidale and the stratum granulosum of the dentate gyrus (DG). Average intensity (F t ) was estimated for each slice by acquiring values in ®ve different areas (5 Q 82.5 mm 2 ) within each hippocampal subregion. Simultaneously, the background intensity (F 0 ) was obtained outside the slices. Forty-eight hours after OGD insult, all cells were killed by 24-h incubation at a low temperature (4°C), and then the ®nal PI¯uorescence (F ®n ) was measured. PI uptake was determined as (
PLA 2 activity was assayed by measuring the amounts of free radiolabelled fatty acids released from the substrates 1-palmitoyl-2-[ 14 C]arachidonoyl-sn-glycero-3-phosphoethanolamine (Amersham Pharmacia, Arlington Heights, IL, USA) (Horigome et al., 1987) . The pyramidal cell layer and the granule cell layer were dissected out immediately and 24 h after OGD, and lysed. Reaction mixture consisted of an aliquot of the required sample, 100 mM Tris-HCl, pH 7.4, 4 mM CaCl 2 ,and 2 mM substrate. After 30 min incubation in the absence or presence of PLA 2 inhibitors at 37°C, the 14 C-fatty acids released were extracted by Dole's method (Horigome et al., 1987) , and the radioactivity was counted.
p-Bromophenacyl bromide (BPB), bromoenol lactone (BEL), ibuprofen and nordihydroguaiaretic acid (NDGA) were purchased from Wako Pure Chemicals (Osaka, Japan). Arachidonyl tri¯uor-omethyl ketone (AACOCF 3 ) was purchased from Biomol Res. Laboratory (Plymouth Meeting, PA, USA). LY311727 was obtained as a gift from E. Mihelich (Eli Lilly and Company, Indianapolis, IN, USA). These drugs were added to culture medium from 40 min before until 40 min after the OGD.
All data are expressed as means T SEM. Statistical signi®cance was evaluated by Tukey's multiple range test following one-way ANOVA. Differences were considered signi®cant if P < 0.05.
Results
Although a number of studies have shown the release of arachidonic acid following transient global ischemia (Rehncrona et al., 1982; Abe et al., 1987; Hsu et al., 1989) , there has been no indication that ischemic conditions actually activate PLA 2 in the hippocampus. Therefore, we ®rst evaluated OGD-induced changes in PLA 2 activity in organotypic cultures of hippocampal slices (Fig. 1 ).
Baseline PLA 2 activity was not equal in the pyramidal cell layer of Ammon's Horn and the granule cell layer of the DG. The activity in the DG was approximately twice as high as in Ammon's Horn.
Exposure to OGD induced an » 2-fold increase in the PLA 2 activity of Ammon's Horn whilst it did not affect that of the DG in the same cultures. The PLA 2 activity in Ammon's Horn remained enhanced until at least 24 h after OGD exposure (data not shown). This increase in PLA 2 activity was blocked by BPB, a broad-spectrum inhibitor of PLA 2 (Fig. 1B) . To determine which subtype of PLA 2 was activated by OGD exposure, we examined the effect of three selective inhibitors of PLA 2 . The OGD-increased activity was prevented by the selective cPLA 2 inhibitor AACOCF 3 , but not by the selective iPLA 2 inhibitor BEL or the selective sPLA 2 inhibitor LY311727. The data suggest that PLA 2 activation following OGD exposure is almost fully attributable to changes in cPLA 2 activity.
The cell death in cultured hippocampal slices was assessed by PĪ uorescence (Macklis & Madison, 1990) (Fig. 2) . Although faint PI uptake was detected in intact slices, evident PI¯uorescent signals appeared 24 h after OGD exposure. A signi®cant increase in PI uptake was observed in the pyramidal cell layer of the CA1 and CA3 subregions but the neurons in the DG were relatively resistant to the OGD insult. The order of hippocampal vulnerability was the CA1 region, the CA3 region and the DG, which closely resembles a rank of vulnerability in cerebral ischemia in vivo. Therefore, we investigated the involvement of PLA 2 in the OGD-induced neuronal death. PLA 2 activity was assessed immediately after hippocampal slices were exposed to OGD for 35 min. OGD caused a 2-fold increase in PLA 2 activity in the pyramidal cell layer of the Ammon's horn, but no change was observed in the activity in the granule cell layer of the DG. **P < 0.01 vs. Intact. (B) PLA 2 activity was measured in the presence of diverse inhibitors of PLA 2 , i.e. 10 mM BPB, 10 mM AACOCF 3 , 10 mM BEL and 10 mM LY311727. BPB and AACOCF 3 effectively blocked OGD-increased PLA 2 activity. The ordinate is expressed as a percentage of baseline PLA 2 activity obtained from intact slices. Data represent means T SEM (12 slices). **P < 0.01 vs. None.
The cell death was ef®ciently attenuated by BPB in a concentrationdependent manner, whilst BPB per se had no apparent effect on the cell survival in intact slices (Fig. 2) . This result indicates that PLA 2 activity contributes causally to hippocampal ischemic injury. Thus, we examined which subtype of PLA 2 mediates the OGD-induced neuronal death. Pharmacological blockade of cPLA 2 by AACOCF 3 signi®cantly inhibited the neuronal death in the CA1 region (Fig. 3A) . BEL or LY311727 was virtually ineffective. Similar results were obtained for OGD-induced neuronal death in the CA3 region (data not shown). Incidentally, none of these inhibitors alone affected PI uptake in intact slices (data not shown). Therefore, cPLA 2 is likely to play a pivotal role in hippocampal ischemic injury.
Although arachidonic acid is released from membrane phospholipids in response to ischemic stimulus, it rapidly decreases during postischemic period, as compared with other PLA 2 products such as free fatty acids and lysophospholipids (Yoshida et al., 1986) , which suggests that the ischemic stimulus also facilitates arachidonate metabolisms, probably via cyclooxygenase and lipoxygenase. We therefore addressed the possible involvement of cyclooxygenase and lipoxygenase in the OGD insult. The cyclooxygenase inhibitor ibuprofen did not protect against the neuronal death, whereas the lipoxygenase inhibitor NDGA signi®cantly reduced the OGD-elicited neuronal damage (Fig. 3B) .
Discussion
Although the involvement of PLA 2 in ischemic injury of the hippocampus has received much attention in recent years (Shimizu & Wolfe, 1990; , there has been no direct evidence for the correlation between PLA 2 and neuronal degeneration. Using organotypic cultures, we have shown for the ®rst time that OGD exposure causes an increase in hippocampal PLA 2 activity, and also that blockade of PLA 2 activity during OGD exposure improves survival of hippocampal neurons.
Because our organotypic cultures were essentially tiny in size, we were unable to precisely assess the PLA 2 activity when the CA1 and CA3 regions were isolated. Therefore, we measured the total PLA 2 activity in the whole Ammon's horn. Thus, we could not determine whether the OGD-induced PLA 2 activation re¯ects a change in either one or both of the CA1 and CA3 regions. Actually, the CA1 region is more vulnerable to OGD injury than is the CA3 region, but the PLA 2 inhibitors prevented neuronal damages equally in the CA1 and CA3 regions. Therefore, we consider that the PLA 2 activation is involved in neuronal death of the CA3 region as well as the CA1 regions. For the same reason, we could not examine whether PLA 2 plays a similar role in the hilus of the DG, although this part of the DG is known to be a region showing the highest ischemic vulnerability. Whether or not PLA 2 mediates ischemia-induced neuronal death in the hilus requires further investigation. Several reports showed a dramatic increase in expression of PLA 2 mRNA after transient forebrain ischemia (Lauritzen et al., 1994; Owada et al., 1994) ; therefore it is likely that the increases in PLA 2 activity participates in the later stage of ischemic injury. However, we showed that the PLA 2 activity is enhanced even immediately after OGD insult. The result suggests a post-translational modi®cation of pre-existing PLA 2 proteins. cPLA 2 activity depends on the concentration of Ca 2+ and the phosphorylation (Clark et al., 1991; Lin et al., 1993; Muthalif et al., 1996) . Such modulations of the enzyme activity may be involved in the rapid activation of PLA 2 following ischemia. On the other hand, glutamate receptor activation induces a rapid increase in release of arachidonic acid, which is assumed to contribute to the induction of hippocampal synaptic plasticity (Dumuis et al., 1988; Drapeau et al., 1990; Bramham et al., 1994) . Thus, it is possible that the PLA 2 activation under ischemic conditions involves a common molecular mechanism for synaptic plasticity.
A number of studies addressed the contribution of arachidonic acid and its metabolites to neuronal death or survival. In primary cultures of hippocampal neurons, arachidonic acid at a low concentration (1 mM) exerts its trophic effect but shows profound severe toxicity at concentrations over 5 mM (Okuda et al., 1994) . Recently, McGinty et al. (2000) indicated that cyclooxygenase-2-derived prostaglandins probably serve as a protective mediator in PC12 cells. In contrast, Nakayama et al. (1998) showed harmful effects of cyclooxygenase-2 and prostaglandin E 2 on hippocampal neuron survival. Furthermore, Murphy et al. (1989) suggested that lipoxygenase-derived metabolites mediate glutamate-induced toxicity in N18-RE-105 neuronal cell line. These complicated observations make it dif®cult to conclude whether PLA 2 activation contributes to cell death or survival. However, most important is the eventual consequence at tissue levels rather than the effect of each mediator on individual cells. Here we have shown that blockade of PLA 2 prevents neuronal death in hippocampal organotypic cultures, suggesting that, at least from a macroscopic viewpoint (tissue levels), PLA 2 activation exerts aversive effects on neuron survival under ischemic conditions. In this context, the result that the PLA 2 activity was unchanged in the DG following OGD exposure may explain the minimal ischemic damage to DG neurons. On the other hand, considering the high level of baseline PLA 2 activity in the DG, the DG neurons may be intrinsically equipped with protective machineries against the toxic effects of PLA 2 metabolites. Thus, elucidating mechanisms underlying the survival of DG neurons even under high levels of PLA 2 activity may provide a new therapeutic target for the development of neuroprotective agents.
Because arachidonic acid is known to modulate glutamate transporter activity in the central nervous system (Zerangue et al., 1995) , it is possible that arachidonic acid itself directly triggers ischemic injury. However, our data showed that OGD-induced neuronal death was ef®ciently prevented by pharmacological blockade of lipoxygenase, but not of cyclooxygenase. Very recently, we also reported that 12-lipoxygenase may play a pivotal role in hippocampal ischemic injury (Arai et al., 2001) . Indeed, the receptor for 12-HETE, one of the major 12-lipoxygenase metabolites, is shown to interact with steroid receptor coactivator-1 (Kurahashi et al., 2000) , which may in turn be recruited by several nuclear receptors, e.g. oestrogen, glucocorticoid, progesterone, thyroid hormone, and the 9-cis retinoic acid receptor (On Äate et al., 1995) . Importantly, all these steroid hormones are potent regulators of apoptosis in various types of cells (Kiess & Gallaher, 1998) . Such steroid receptor recruitment may be involved in the PLA 2 -mediated ischemic injury.
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AACOCF 3 , arachidonyl tri¯uoromethyl ketone; BEL, bromoenol lactone; BPB, bromophenacyl bromide; cPLA 2 , cytosolic Ca 2+ -dependent cytosolic phospholipase A 2 ; DG, dentate gyrus; HBSS, Hanks' balanced salt solution; iPLA 2 , Ca 2+ -independent phospholipase A 2 ; NDGA, nordihydroguaiaretic acid; OGD, oxygen-glucose deprivation; PI, propidium iodide; PLA 2 , phospholipase A 2 ; sPLA 2 , secretory form of phospholipase A 2 FIG. 3. Effects of various inhibitors on OGD-induced neuronal death in hippocampal slice cultures. PI uptake was assessed in the CA1 pyramidal cell layer 24 h after OGD insult. Open columns represent intact slices. Closed columns and hatched columns represent the slices exposed to OGD alone or in the presence of inhibitors, respectively. (A) Effects of PLA 2 inhibitors on the OGD injury. OGD-induced neuronal death was signi®cantly attenuated by AACOCF 3 . (B) Effects of inhibitors of arachidonate cascades on the OGD injury. OGD-induced neuronal death was effectively prevented by NDGA. Data were means T SEM of eight slices. **P < 0.01 vs. Intact; # P < 0.05, ## P < 0.01 vs. 0 mM of corresponding inhibitors.
